281232-91-5 Usage
Uses
Used in Pharmaceutical Industry:
3'-(METHOXYCARBONYL)[1,1'-BIPHENYL]-4-CARBOXYLIC ACID is used as an intermediate in organic synthesis for the development of pharmaceutical compounds. Its unique structure allows it to be a key component in the creation of various drugs with specific therapeutic properties.
Used in Synthesis of Sialosides:
In the field of organic chemistry, 3'-(METHOXYCARBONYL)[1,1'-BIPHENYL]-4-CARBOXYLIC ACID is used as a crucial intermediate in the synthesis of Sialosides. These compounds function as CD22-specific inhibitors, which have potential applications in the treatment of various diseases, particularly those involving the immune system.
Used in Research and Development:
Due to its unique structure and properties, 3'-(METHOXYCARBONYL)[1,1'-BIPHENYL]-4-CARBOXYLIC ACID is also utilized in research and development for exploring new chemical reactions, synthesis pathways, and potential applications in various industries, including materials science, pharmaceuticals, and chemical engineering.
Check Digit Verification of cas no
The CAS Registry Mumber 281232-91-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,1,2,3 and 2 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 281232-91:
(8*2)+(7*8)+(6*1)+(5*2)+(4*3)+(3*2)+(2*9)+(1*1)=125
125 % 10 = 5
So 281232-91-5 is a valid CAS Registry Number.
281232-91-5Relevant academic research and scientific papers
Design, synthesis, and structure-affinity relationships of novel series of sialosides as CD22-specific inhibitors
Abdu-Allah, Hajjaj H. M.,Tamanaka, Taichi,Yu, Jie,Zhuoyuan, Lu,Sadagopan, Magesh,Adachi, Takahiro,Tsubata, Takeshi,Kelm, Soerge,Ishida, Hideharu,Kiso, Makoto
body text, p. 6665 - 6681 (2009/11/30)
Sialosides incorporating substituted amides or amines at 9-position of sialic acid moiety have been synthesized and evaluated as CD22 inhibitors. Several derivatives exhibited inhibitory potency in sub- to low micromolar range (e. g., 80, 9d, 9g, and 9k s
SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL) BENZOHETEROARYL COMPOUNDS
-
, (2008/06/13)
This invention is directed to an (aminoiminomethyl or aminomethyl) benzoheteroaryl compound of formula I which is useful for inhibiting the activity of Factor Xa by combining said compound with a composition containing Factor Xa. The present invention is also directed to compositions containing compounds of the formula I, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.
